Supply and demand for plasma-derived medicinal products - A critical reassessment amid the COVID-19 pandemic.

Hartmann, Jan; Klein, Harvey G

Hartmann, Jan; Klein, Harvey G.

Hartmann J; Department of Medical Affairs and Clinical Development, Haemonetics Corporation, Boston, Massachusetts, USA.
Klein HG; Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

Transfusion ; 60(11): 2748-2752, 2020 11.

Article in English | MEDLINE | ID: covidwho-767659

Subject(s)

Biological Products/supply & distribution; Blood Banks; Blood Donors/supply & distribution; COVID-19/epidemiology; Health Services Needs and Demand; Biological Products/blood; Biological Products/isolation & purification; Blood Banks/organization & administration; Blood Banks/standards; Blood Banks/statistics & numerical data; Blood Banks/supply & distribution; Blood Donors/statistics & numerical data; COVID-19/blood; COVID-19/therapy; Health Services Needs and Demand/organization & administration; Health Services Needs and Demand/standards; Health Services Needs and Demand/statistics & numerical data; History, 21st Century; Humans; Immunization, Passive; Immunoglobulins, Intravenous/blood; Immunoglobulins, Intravenous/isolation & purification; Needs Assessment; Nomograms; Pandemics; Plasma/chemistry; Time Factors; United States/epidemiology; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biological Products / Blood Banks / Blood Donors / COVID-19 / Health Services Needs and Demand Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Transfusion Year: 2020 Document Type: Article Affiliation country: Trf.16078

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google